{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:32:00Z","timestamp":1785461520096,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99469","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T17:29:09Z","timestamp":1765992549000},"source":"Crossref","is-referenced-by-count":1,"title":["Anthracosilicosis Mimicking Primary or Secondary Lung Malignancy in a Patient With a History of Treated Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Youseff","family":"Elrayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rton","family":"Mik\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hany","family":"Elrayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59614","article-title":"18F-fluorodeoxyglucose-avid benign anthracotic lymph nodes mimicking malignancy","volume":"16","author":"Giri S","year":"2024","unstructured":"Giri S, Kumar L, Mane K, Uppin MS, Bhrugumalla S, Sundaram S. 18F-fluorodeoxyglucose-avid benign anthracotic lymph nodes mimicking malignancy. Cureus. 2024, 16:e59614. 10.7759\/cureus.59614","journal-title":"Cureus"},{"key":"ref2","article-title":"Microscopic features of lymph-node anthracosilicosis and false-positive FDG uptake in silicosis","volume":"18","author":"Murakami J","year":"2023","unstructured":"Murakami J, Sato K, Nakamura H, et al.. Microscopic features of lymph-node anthracosilicosis and false-positive FDG uptake in silicosis. J Cardiothorac Surg. 2023, 18:1-6.","journal-title":"J Cardiothorac Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31821a2978","article-title":"Anthracotic solitary pulmonary nodule imitating lung malignancy on F-18 FDG PET\/CT imaging","volume":"36","author":"Canbaz F","year":"2011","unstructured":"Canbaz F, Kefeli M, Sahin Z, Basoglu T. Anthracotic solitary pulmonary nodule imitating lung malignancy on F-18 FDG PET\/CT imaging. Clin Nucl Med. 2011, 36:955-6. 10.1097\/RLU.0b013e31821a2978","journal-title":"Clin Nucl Med"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2020.01.040","article-title":"A case of nodal anthracosis presenting as PET-positive lymphadenopathy","volume":"95","author":"Alzubi J","year":"2020","unstructured":"Alzubi J, Smith E, Hennessey T, et al.. A case of nodal anthracosis presenting as PET-positive lymphadenopathy. Mayo Clin Proc. 2020, 95:819-25.","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0972-3919.187470","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in a rare case of carcinoma stomach with concomitant silicosis","volume":"31","author":"Sasikumar A","year":"2016","unstructured":"Sasikumar A, Joy A, Unni M, Madhavan J. Fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in a rare case of carcinoma stomach with concomitant silicosis. Indian J Nucl Med. 2016, 31:307-8. 10.4103\/0972-3919.187470","journal-title":"Indian J Nucl Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A2792","article-title":"A case of a false-positive anthracotic node on PET scan","volume":"211","author":"Tangney N","year":"2025","unstructured":"Tangney N. A case of a false-positive anthracotic node on PET scan. Am J Respir Crit Care Med. 2025, 211:2792.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.107.048983","article-title":"Bilateral hilar foci on 18F-FDG PET in patients: benign versus malignant etiology","volume":"49","author":"Karam M","year":"2008","unstructured":"Karam M, Kaur A, Lamonica G, et al.. Bilateral hilar foci on 18F-FDG PET in patients: benign versus malignant etiology. J Nucl Med. 2008, 49:1429-36.","journal-title":"J Nucl Med"},{"key":"ref8","article-title":"Mediastinal lymph-node FDG positivity in oesophageal adenocarcinoma: anthracotic pseudotumor mimic","volume":"8","author":"Haidar M","year":"2017","unstructured":"Haidar M, Shafik A, Boulos F, et al.. Mediastinal lymph-node FDG positivity in oesophageal adenocarcinoma: anthracotic pseudotumor mimic. J Nucl Med Radiat Ther. 2017, 8:341-5.","journal-title":"J Nucl Med Radiat Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.773041","article-title":"Differentiation between malignant and benign pulmonary nodules by using automated three-dimensional high-resolution representation learning with fluorodeoxyglucose positron emission tomography-computed tomography","volume":"9","author":"Lai YC","year":"2022","unstructured":"Lai YC, Wu KC, Tseng NC, Chen YJ, Chang CJ, Yen KY, Kao CH. Differentiation between malignant and benign pulmonary nodules by using automated three-dimensional high-resolution representation learning with fluorodeoxyglucose positron emission tomography-computed tomography. Front Med (Lausanne). 2022, 9:773041. 10.3389\/fmed.2022.773041","journal-title":"Front Med (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65411","article-title":"Silico-tuberculosis mimicking malignancy","volume":"16","author":"Elango R","year":"2024","unstructured":"Elango R, Kailash A, Verma G, Rudhramoorty P. Silico-tuberculosis mimicking malignancy. Cureus. 2024, 16:e65411. 10.7759\/cureus.65411","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61130","article-title":"Elevated levels of the cancer marker neuron-specific enolase in a patient with coexisting silicosis and sarcoidosis","volume":"16","author":"Davaajav K","year":"2024","unstructured":"Davaajav K, Dagva D, Dashtseren I, Takahashi Y, Nakayama T. Elevated levels of the cancer marker neuron-specific enolase in a patient with coexisting silicosis and sarcoidosis. Cureus. 2024, 16:e61130. 10.7759\/cureus.61130","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i5.1016","article-title":"Serum neuron-specific enolase: a promising biomarker of silicosis","volume":"9","author":"Huang HB","year":"2021","unstructured":"Huang HB, Huang JL, Xu XT, Huang KB, Lin YJ, Lin JB, Zhuang XB. Serum neuron-specific enolase: a promising biomarker of silicosis. World J Clin Cases. 2021, 9:1016-25. 10.12998\/wjcc.v9.i5.1016","journal-title":"World J Clin Cases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.03.005","article-title":"Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis","volume":"433","author":"Fang SC","year":"2014","unstructured":"Fang SC, Zhang HT, Wang CY, Zhang YM. Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis. Clin Chim Acta. 2014, 433:123-7. 10.1016\/j.cca.2014.03.005","journal-title":"Clin Chim Acta"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040764","article-title":"How the management of biochemical recurrence in prostate cancer will be modified by the concept of anticipation and incrementation of therapy","volume":"16","author":"Sciarra A","year":"2024","unstructured":"Sciarra A, Santarelli V, Salciccia S, et al.. How the management of biochemical recurrence in prostate cancer will be modified by the concept of anticipation and incrementation of therapy. Cancers (Basel). 2024, 16:10.3390\/cancers16040764","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification","volume":"27","author":"Shore ND","year":"2024","unstructured":"Shore ND, Moul JW, Pienta KJ, Czernin J, King MT, Freedland SJ. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. Prostate Cancer Prostatic Dis. 2024, 27:192-201. 10.1038\/s41391-023-00712-z","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003891","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy","volume":"211","author":"Morgan TM","year":"2024","unstructured":"Morgan TM, Boorjian SA, Buyyounouski MK, et al.. Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol. 2024, 211:518-25. 10.1097\/JU.0000000000003891","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.05.026","article-title":"Epidemiology of high-risk biochemical recurrence after prostate cancer treatment","volume":"8","author":"Falagario UG","year":"2025","unstructured":"Falagario UG, Pellegrino F, Bj\u00f6rnebo L, et al.. Epidemiology of high-risk biochemical recurrence after prostate cancer treatment. Eur Urol Oncol. 2025, 8:1078-86. 10.1016\/j.euo.2025.05.026","journal-title":"Eur Urol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434778-anthracosilicosis-mimicking-primary-or-secondary-lung-malignancy-in-a-patient-with-a-history-of-treated-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T17:29:10Z","timestamp":1765992550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434778-anthracosilicosis-mimicking-primary-or-secondary-lung-malignancy-in-a-patient-with-a-history-of-treated-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.99469","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}